Abbott Laboratories
ABT
$132.41
Share price
0.10%
Change (1 day)
24.25%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Net assets
Net assets on the balance sheet as of March 2025 : $49.06 Billion USD
According to Abbott Laboratories's latest financial reports the company has $49.06 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Abbott Laboratories - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$47.90 B | 23.37% |
| 2023-12-31 | $$38.82 B | 5.21% |
| 2022-12-31 | $$36.90 B | 2.45% |
| 2021-12-31 | $$36.02 B | 9.15% |
| 2020-12-31 | $$33.00 B | 5.44% |
| 2019-12-31 | $$31.30 B | 1.88% |
| 2018-12-31 | $$30.72 B | -1.21% |
| 2017-12-31 | $$31.09 B | 50.11% |
| 2016-12-31 | $$20.71 B | -2.86% |
| 2015-12-31 | $$21.32 B | -1.45% |
| 2014-12-31 | $$21.63 B | -14.36% |
| 2013-12-31 | $$25.26 B | -5.77% |
| 2012-12-31 | $$26.81 B | 9.32% |
| 2011-12-31 | $$24.52 B | 7.74% |
| 2010-12-31 | $$22.76 B | -0.58% |
| 2009-12-31 | $$22.89 B | 30.71% |
| 2008-12-31 | $$17.51 B | -1.46% |
| 2007-12-31 | $$17.77 B | 26.5% |
| 2006-12-31 | $$14.05 B | -2.5% |
| 2005-12-31 | $$14.41 B | 0.62% |
| 2004-12-31 | $$14.32 B | 9.59% |
| 2003-12-31 | $$13.07 B | 22.58% |
| 2002-12-31 | $$10.66 B | 17.72% |
| 2001-12-31 | $$9.05 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $78.10 B | 59.20% | 🇺🇸 USA |
 Pfizer PFE | $90.63 B | 84.73% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $49.48 B | 0.86% | 🇺🇸 USA |
 Hologic HOLX | $4.61 B | -90.59% | 🇺🇸 USA |
 Medtronic MDT | $49.61 B | 1.12% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | $17.44 B | -64.44% | 🇺🇸 USA |
 Boston Scientific BSX | $22.44 B | -54.25% | 🇺🇸 USA |
 AstraZeneca AZN | $41.13 B | -16.17% | 🇬🇧 UK |
 Novartis NVS | $38.45 B | -21.63% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $17.66 B | -63.99% | 🇬🇧 UK |